Exports In 2022, South Africa exported $330M in Vaccines, blood, antisera, toxins and cultures, making it the 28th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 44th most exported product in South Africa. The main destination of Vaccines, blood, antisera, toxins and cultures exports from South Africa are: Belgium ($273M), Namibia ($9.18M), Zambia ($6.81M), Botswana ($5.95M), and Zimbabwe ($5.17M).
The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of South Africa between 2021 and 2022 were Burundi ($2M), Zambia ($1.83M), and Armenia ($1.34M).
Imports In 2022, South Africa imported $528M in Vaccines, blood, antisera, toxins and cultures, becoming the 56th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 37th most imported product in South Africa. South Africa imports Vaccines, blood, antisera, toxins and cultures primarily from: France ($112M), Germany ($102M), United States ($57.4M), Switzerland ($49.8M), and Ireland ($49.5M).
The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for South Africa between 2021 and 2022 were Argentina ($3.68M), France ($3.1M), and Austria ($2.84M).